Does TACROLIMUS Cause Acute myeloid leukaemia? 159 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 159 reports of Acute myeloid leukaemia have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.2% of all adverse event reports for TACROLIMUS.
159
Reports of Acute myeloid leukaemia with TACROLIMUS
0.2%
of all TACROLIMUS reports
56
Deaths
29
Hospitalizations
How Dangerous Is Acute myeloid leukaemia From TACROLIMUS?
Of the 159 reports, 56 (35.2%) resulted in death, 29 (18.2%) required hospitalization, and 17 (10.7%) were considered life-threatening.
Is Acute myeloid leukaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 159 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Acute myeloid leukaemia?
CYCLOPHOSPHAMIDE (1,675)
VENETOCLAX (1,591)
DOXORUBICIN (1,503)
AZACITIDINE (1,156)
ETOPOSIDE (1,069)
VINCRISTINE (984)
CYTARABINE (837)
CARBOPLATIN (812)
RITUXIMAB (735)
METHOTREXATE (728)
Which TACROLIMUS Alternatives Have Lower Acute myeloid leukaemia Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB